In a report released on February 5, Charles Weston from RBC Capital maintained a Buy rating on Sartorius Stedim Biotech (0RG8 – Research ...
In a report released today, Charles Weston from RBC Capital maintained a Hold rating on Sartorius (0NIR – Research Report), with a price target ...
In a challenging environment, Sartorius Stedim Biotech, a leading provider of innovative technologies for the manufacture of ...
Shares of Danaher Corporation (NYSE:DHR) climbed 2%, while Repligen Corporation (NASDAQ:RGEN) saw a 3% increase, Thermo ...
Shares in Sartorius jumped 15.6% on Tuesday after the Franco-German lab supplies maker's preliminary annual results beat expectations and despite a cautious outlook for 2025.
Sartorius (SARTF) jumps as the company projects a positive outlook with its 2024 results sending its U.S. peers, Repligen ...
Rad's challenges in the life sciences tools market, cautious approach, R&D spending, stake in Sartorius, and growth potential ...
Sartorius AG (SARTF) reports robust order growth and efficiency savings, despite facing headwinds in the Lab Products & Services division.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Sartorius AG (ETR:SATG) (SRT3:GR) (OTC: SARTF) stock remained under the scrutiny of Bernstein SocGen Group, as the firm reiterated its Underperform rating and a price target of EUR194.00. The ...
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has launched the single- use ultrafilter Sartocon® Slice 50. The new crossflow filter device is ...
Sartorius Stedim Biotech SA (SDMHF) reports steady revenue growth and robust order intake, while addressing market pressures and strategic expansions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results